36C24819R0003-003.xlsx
XLSX spreadsheet 239 KB Posted
- Solicitation number
- 36C24819R0003
About this file
This is a pre-solicitation notice for a request for proposal for whole blood and blood products for the Department of Veterans Affairs Veterans Integrated Service Network 8. The anticipated RFP will be for a firm-fixed price indefinite delivery/indefinite quantity contract with a base period of 12 months and four 12-month option periods. The estimated value is over $32.5 million. The contract is set for award as a single winner but allows for multiple awards if in the government's best interest. Products will be delivered to six VA medical centers across Florida, Puerto Rico, and West Palm Beach. Questions are due by October 2nd and the RFP is planned for release on October 12th. Evaluation will consider pricing and ability to serve the covered geographic locations.
36C24819R0003 ATTACHMENT A PRICE_COST SCHEDULE 5 Yr Ordering All Sites.xlsx
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C24819R0003_0002.docx | DOCX document | |
| Answers_to_Questions_VISN_8_Solicitation_36C24819R0003.pdf | ||
| 36C24819R0003-0001001.xlsx | XLSX spreadsheet | |
| 36C24819R0003-0001000.docx | DOCX document | |
| 36C24819R0003-001.docx | DOCX document | |
| 36C24819R0003-002.docx | DOCX document | |
| 36C24819R0003-000.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Bay Pines
| ATTACHMENT A: PRICE/COST SCHEDULE - BAY PINES | ||||||
| Bay Pines VA Healthcare System, 10000 Bay Pines Blvd, Bay Pines, FL 33744 | ||||||
| BASE YEAR (Estimated Delivery date January 1, 2019 - September 30, 2019 | ||||||
| BLOOD COMPONENTS | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Est Unit Price | Estimated Total Price | |
| 0001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | ||
| 0002 | Whole Blood Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 0003 | Whole Blood Leukoreduced Low | |||||
| Volume Irradiated | 1 | EA | $ - 0 | |||
| 0004 | Whole Blood Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 0005 | Red Blood Cells Leukoreduced | 2348 | EA | $ - 0 | ||
| 0006 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized | 1 | EA | $ - 0 | |||
| 0007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | ||
| 0008 | Red Blood Cells Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| 0009 | Red Blood Cells Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 0010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | ||
| 0011 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | |||
| 0012 | Red Blood Cells Leukoreduced | |||||
| Irradiated Washed | 1 | EA | $ - 0 | |||
| 0013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | |||||
| Neg.,) | 1 | EA | $ - 0 | |||
| 0014 | Red Blood Cells Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 0015 | Red Blood Cells Autologous | |||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | |||
| 0016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 0017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | ||
| 0018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | ||
| 0019 | Cryoprecipitate | 1 | EA | $ - 0 | ||
| 0020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | ||
| 0021 | Pooled Cryoprecipitate (10) | 15 | EA | $ - 0 | ||
| 0022 | Fresh Frozen Plasma | 423 | EA | $ - 0 | ||
| 0023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | ||
| 0024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | ||
| 0025 | Fresh Frozen Plasma ‐ Infant Dose | |||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | |||
| 0026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | ||
| 0027 | Plasma (Liquid) | 1 | EA | $ - 0 | ||
| 0028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | ||
| 0029 | Source Leukocyte | 1 | EA | $ - 0 | ||
| 0030 | Apheresis Platelets (SDP) | |||||
| Leukoreduced | 343 | EA | $ - 0 | |||
| 0031 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 0032 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | |||
| 0033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | ||
| 0034 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | |||
| 0035 | Apheresis Platelets (SDP) Autologous | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 0036 | Apheresis Granulocytes | 1 | EA | $ - 0 | ||
| 0037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | ||
| 0038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 0039 | Pooled Platelets Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | |||||
| CELLULAR LAB | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | ||
| 0041 | SC Plasma Depletion | 1 | EA | $ - 0 | ||
| 0042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | ||
| 0043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | ||
| 0044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | ||
| 0045 | SC Cord Wash Process | 1 | EA | $ - 0 | ||
| 0046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | ||
| 0047 | Stem Cell Freight | 1 | EA | $ - 0 | ||
| 0048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | ||
| 0049 | SC CBC with automated differential | 1 | EA | $ - 0 | ||
| 0050 | SC CBC with manual differential | 1 | EA | $ - 0 | ||
| 0051 | CD34 Test | 1 | EA | $ - 0 | ||
| 0052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | ||
| 0053 | SC Trypan Blue viability | 1 | EA | $ - 0 | ||
| 0054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | ||
| 0055 | SC Sterility Check | 1 | EA | $ - 0 | ||
| 0056 | SC CD3 | 1 | EA | $ - 0 | ||
| 0057 | SC CD4 | 1 | EA | $ - 0 | ||
| 0058 | SC CD8 | 1 | EA | $ - 0 | ||
| 0059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| HLA AND SPECIAL HEMATOLOGY TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0060 | Platelet Crossmatch | 1 | EA | $ - 0 | ||
| 0061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | ||
| 0062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 | ||
| 0063 | Neonate Allo Thrombocytopenia Assessment | 1 | EA | $ - 0 | ||
| 0064 | Platelet Genotyping | 1 | EA | $ - 0 | ||
| 0065 | Platelet Auto Antibodies | 1 | EA | $ - 0 | ||
| 0066 | HLA ABC Typing (Class I) | 1 | EA | $ - 0 | ||
| 0067 | HLA DR/DQ Typing (Class II) | 1 | EA | $ - 0 | ||
| 0068 | HLA for Platelet Pheresis | 1 | EA | $ - 0 | ||
| 0069 | HLA‐Antibody Intermediate Resolution, Basic | 1 | EA | $ - 0 | ||
| 0070 | RBC Genotype Bioarray (HEA) | 1 | EA | $ - 0 | ||
| 0071 | HLA ‐ ABC/DR High Resolution, DQ Low Resolution | 1 | EA | $ - 0 | ||
| 0072 | Heparin Induced Thrombocytopenia Antibody (HIT) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| APHERESIS AND THERAPEUTIC SERVICES | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0073 | HPC Apheresis | 1 | EA | $ - 0 | ||
| 0074 | Photopheresis Procedure | 1 | EA | $ - 0 | ||
| 0075 | Therapeutic Cellular Depletion ‐ WBC | 1 | EA | $ - 0 | ||
| 0076 | Therapeutic Phlebotomy (In Blood | |||||
| Center) | 1 | EA | $ - 0 | |||
| 0077 | Therapeutic phlebotomy ‐ in hospital | 1 | EA | $ - 0 | ||
| 0078 | Therapeutic phlebotomy with | |||||
| replacement fluid ‐ in hospital | 1 | EA | $ - 0 | |||
| 0079 | Red Blood Cell Exchange | 1 | EA | $ - 0 | ||
| 0080 | Therapeutic Cellular Depletion ‐ RBC | 1 | EA | $ - 0 | ||
| 0081 | Therapeutic Cellular Depletion ‐ | |||||
| Platelet | 1 | EA | $ - 0 | |||
| 0082 | Therapeutic Plasma Exchange | 74 | EA | $ - 0 | ||
| 0083 | Red Cell Prime | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| REFERENCE TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0084 | Radsure Label to be Irradiated | 1 | EA | $ - 0 | ||
| 0085 | Irradiation of Unit | 38 | EA | $ - 0 | ||
| 0086 | Deglycerolization of Unit | 1 | EA | $ - 0 | ||
| 0087 | Freeze Unit | 1 | EA | $ - 0 | ||
| 0088 | Freeze & Deglycerolization Unit | 1 | EA | $ - 0 | ||
| 0089 | Pooling unit(s) | 1 | EA | $ - 0 | ||
| 0090 | Thaw Unit | 1 | EA | $ - 0 | ||
| 0091 | RBC Wash | 1 | EA | $ - 0 | ||
| 0092 | Platelet Wash | 1 | EA | $ - 0 | ||
| 0093 | RBC Crossmatch (each additional unit) | 1 | EA | $ - 0 | ||
| 0094 | Non‐crossmatch set up | 1 | EA | $ - 0 | ||
| 0095 | ABO Group | 1 | EA | $ - 0 | ||
| 0096 | RH Type | 1 | EA | $ - 0 | ||
| 0097 | Chemical Treatment | 1 | EA | $ - 0 | ||
| 0098 | Aliquot Bag | 1 | EA | $ - 0 | ||
| 0099 | Confirmatory Draw | 1 | EA | $ - 0 | ||
| 0100 | Platelet (Volume Reduction Fee) | 1 | EA | $ - 0 | ||
| 0101 | Computer Antigen Search (per Antigen) | 1 | EA | $ - 0 | ||
| 0102 | Patient Complete Phenotype, Serologic | 1 | EA | $ - 0 | ||
| 0103 | Reconstitute | 1 | EA | $ - 0 | ||
| 0104 | RBC Antibody Identification | 30 | EA | $ - 0 | ||
| 0105 | Rare Unit | 5 | EA | $ - 0 | ||
| 0106 | Antigen Typing ‐ Single | 230 | EA | $ - 0 | ||
| 0107 | RBC Selected Cell Panel | 1 | EA | $ - 0 | ||
| 0108 | RBC Cell Separation | 1 | EA | $ - 0 | ||
| 0109 | IgG Dissociation | 1 | EA | $ - 0 | ||
| 0110 | Dithiotreitol Treatment | 1 | EA | $ - 0 | ||
| 0111 | Neutralization P1 or Lewis | 1 | EA | $ - 0 | ||
| 0112 | Chloroquine treatment | 1 | EA | $ - 0 | ||
| 0113 | Acid Elution / Cell Elution | 30 | EA | $ - 0 | ||
| 0114 | Donath‐Landsteiner Test | 1 | EA | $ - 0 | ||
| 0115 | Irradiation ‐ Per Random Platelet | 1 | EA | $ - 0 | ||
| 0116 | Rare Donor Search thru American Rare Donor Program (ARDP) | 1 | EA | $ - 0 | ||
| 0117 | Splitting Service | 1 | EA | $ - 0 | ||
| 0118 | Type and Screen | 30 | EA | $ - 0 | ||
| 0119 | ABO Group & Rh Type | 75 | EA | $ - 0 | ||
| 0120 | Antibody Screen (Indirect Coombs) | 15 | EA | $ - 0 | ||
| 0121 | RBC Antibody Titer | 1 | EA | $ - 0 | ||
| 0122 | Direct Antiglobulin IgG (Direct Coombs) | 63 | EA | $ - 0 | ||
| 0123 | Direct Antiglobulin DAT C3 | 1 | EA | $ - 0 | ||
| 0124 | Fetal Screen | 1 | EA | $ - 0 | ||
| 0125 | Kleihauer ‐ Betke | 1 | EA | $ - 0 | ||
| 0126 | CMV Test | 1 | EA | $ - 0 | ||
| 0127 | Sickle Cell Screen | 6 | EA | $ - 0 | ||
| 0128 | LUI Elution | 1 | EA | $ - 0 | ||
| 0129 | RBC Antibody Panel | 158 | EA | $ - 0 | ||
| 0130 | Transfusion Reaction Work Up | 5 | EA | $ - 0 | ||
| 0131 | RBC Antigen Typing | 32 | EA | $ - 0 | ||
| 0132 | Adsorption | 32 | EA | $ - 0 | ||
| 0133 | Cold Agglutinin Titer | 1 | EA | $ - 0 | ||
| 0134 | ABO RH Cord | 1 | EA | $ - 0 | ||
| 0135 | Sterile Doc Quad Pack | 1 | EA | $ - 0 | ||
| 0136 | Enzyme Treatment | 2 | EA | $ - 0 | ||
| 0137 | Lookback | 1 | EA | $ - 0 | ||
| 0138 | Crossmatch ‐ Electronic | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| OTHER TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0139 | NAT (HIV ‐ I, HBV and HCV RNA) | |||||
| DONOR ONLY | 1 | EA | $ - 0 | |||
| 0140 | Non‐Donor Infectious Disease Markers 3327 | 1 | EA | $ - 0 | ||
| 0141 | Non‐Donor Infectious Disease Markers 3486, no ABO/Rh | 1 | EA | $ - 0 | ||
| 0142 | White Blood Cell Counts by Flow Cytometry | 1 | EA | $ - 0 | ||
| 0143 | Cryoprecipitate QC | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 |
TOTAL $ - 0
| OPTION YEAR ONE (October 1, 2019 - September 2020) | ||||||
| BLOOD COMPONENTS | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | ||
| 1002 | Whole Blood Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 1003 | Whole Blood Leukoreduced Low | |||||
| Volume Irradiated | 1 | EA | $ - 0 | |||
| 1004 | Whole Blood Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 1005 | Red Blood Cells Leukoreduced | 2348 | EA | $ - 0 | ||
| 1006 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized | 1 | EA | $ - 0 | |||
| 1007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | ||
| 1008 | Red Blood Cells Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| 1009 | Red Blood Cells Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 1010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | ||
| 1011 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | |||
| 1012 | Red Blood Cells Leukoreduced | |||||
| Irradiated Washed | 1 | EA | $ - 0 | |||
| 1013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | |||||
| Neg.,) | 1 | EA | $ - 0 | |||
| 1014 | Red Blood Cells Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 1015 | Red Blood Cells Autologous | |||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | |||
| 1016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 1017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | ||
| 1018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | ||
| 1019 | Cryoprecipitate | 1 | EA | $ - 0 | ||
| 1020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | ||
| 1021 | Pooled Cryoprecipitate (10) | 15 | EA | $ - 0 | ||
| 1022 | Fresh Frozen Plasma | 423 | EA | $ - 0 | ||
| 1023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | ||
| 1024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | ||
| 1025 | Fresh Frozen Plasma ‐ Infant Dose | |||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | |||
| 1026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | ||
| 1027 | Plasma (Liquid) | 1 | EA | $ - 0 | ||
| 1028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | ||
| 1029 | Source Leukocyte | 1 | EA | $ - 0 | ||
| 1030 | Apheresis Platelets (SDP) | |||||
| Leukoreduced | 343 | EA | $ - 0 | |||
| 1031 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 1032 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | |||
| 1033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | ||
| 1034 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | |||
| 1035 | Apheresis Platelets (SDP) Autologous | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 1036 | Apheresis Granulocytes | 1 | EA | $ - 0 | ||
| 1037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | ||
| 1038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 1039 | Pooled Platelets Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | |||||
| CELLULAR LAB | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | ||
| 1041 | SC Plasma Depletion | 1 | EA | $ - 0 | ||
| 1042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | ||
| 1043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | ||
| 1044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | ||
| 1045 | SC Cord Wash Process | 1 | EA | $ - 0 | ||
| 1046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | ||
| 1047 | Stem Cell Freight | 1 | EA | $ - 0 | ||
| 1048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | ||
| 1049 | SC CBC with automated differential | 1 | EA | $ - 0 | ||
| 1050 | SC CBC with manual differential | 1 | EA | $ - 0 | ||
| 1051 | CD34 Test | 1 | EA | $ - 0 | ||
| 1052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | ||
| 1053 | SC Trypan Blue viability | 1 | EA | $ - 0 | ||
| 1054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | ||
| 1055 | SC Sterility Check | 1 | EA | $ - 0 | ||
| 1056 | SC CD3 | 1 | EA | $ - 0 | ||
| 1057 | SC CD4 | 1 | EA | $ - 0 | ||
| 1058 | SC CD8 | 1 | EA | $ - 0 | ||
| 1059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| HLA AND SPECIAL HEMATOLOGY TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1060 | Platelet Crossmatch | 1 | EA | $ - 0 | ||
| 1061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | ||
| 1062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 | ||
| 1063 | Neonate Allo Thrombocytopenia Assessment | 1 | EA | $ - 0 | ||
| 1064 | Platelet Genotyping | 1 | EA | $ - 0 | ||
| 1065 | Platelet Auto Antibodies | 1 | EA | $ - 0 | ||
| 1066 | HLA ABC Typing (Class I) | 1 | EA | $ - 0 | ||
| 1067 | HLA DR/DQ Typing (Class II) | 1 | EA | $ - 0 | ||
| 1068 | HLA for Platelet Pheresis | 1 | EA | $ - 0 | ||
| 1069 | HLA‐Antibody Intermediate Resolution, Basic | 1 | EA | $ - 0 | ||
| 1070 | RBC Genotype Bioarray (HEA) | 1 | EA | $ - 0 | ||
| 1071 | HLA ‐ ABC/DR High Resolution, DQ Low Resolution | 1 | EA | $ - 0 | ||
| 1072 | Heparin Induced Thrombocytopenia Antibody (HIT) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| APHERESIS AND THERAPEUTIC SERVICES | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1073 | HPC Apheresis | 1 | EA | $ - 0 | ||
| 1074 | Photopheresis Procedure | 1 | EA | $ - 0 | ||
| 1075 | Therapeutic Cellular Depletion ‐ WBC | 1 | EA | $ - 0 | ||
| 1076 | Therapeutic Phlebotomy (In Blood | |||||
| Center) | 1 | EA | $ - 0 | |||
| 1077 | Therapeutic phlebotomy ‐ in hospital | 1 | EA | $ - 0 | ||
| 1078 | Therapeutic phlebotomy with | |||||
| replacement fluid ‐ in hospital | 1 | EA | $ - 0 | |||
| 1079 | Red Blood Cell Exchange | 1 | EA | $ - 0 | ||
| 1080 | Therapeutic Cellular Depletion ‐ RBC | 1 | EA | $ - 0 | ||
| 1081 | Therapeutic Cellular Depletion ‐ | |||||
| Platelet | 1 | EA | $ - 0 | |||
| 1082 | Therapeutic Plasma Exchange | 74 | EA | $ - 0 | ||
| 1083 | Red Cell Prime | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| REFERENCE TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1084 | Radsure Label to be Irradiated | 1 | EA | $ - 0 | ||
| 1085 | Irradiation of Unit | 38 | EA | $ - 0 | ||
| 1086 | Deglycerolization of Unit | 1 | EA | $ - 0 | ||
| 1087 | Freeze Unit | 1 | EA | $ - 0 | ||
| 1088 | Freeze & Deglycerolization Unit | 1 | EA | $ - 0 | ||
| 1089 | Pooling unit(s) | 1 | EA | $ - 0 | ||
| 1090 | Thaw Unit | 1 | EA | $ - 0 | ||
| 1091 | RBC Wash | 1 | EA | $ - 0 | ||
| 1092 | Platelet Wash | 1 | EA | $ - 0 | ||
| 1093 | RBC Crossmatch (each additional unit) | 1 | EA | $ - 0 | ||
| 1094 | Non‐crossmatch set up | 1 | EA | $ - 0 | ||
| 1095 | ABO Group | 1 | EA | $ - 0 | ||
| 1096 | RH Type | 1 | EA | $ - 0 | ||
| 1097 | Chemical Treatment | 1 | EA | $ - 0 | ||
| 1098 | Aliquot Bag | 1 | EA | $ - 0 | ||
| 1099 | Confirmatory Draw | 1 | EA | $ - 0 | ||
| 1100 | Platelet (Volume Reduction Fee) | 1 | EA | $ - 0 | ||
| 1101 | Computer Antigen Search (per Antigen) | 1 | EA | $ - 0 | ||
| 1102 | Patient Complete Phenotype, Serologic | 1 | EA | $ - 0 | ||
| 1103 | Reconstitute | 1 | EA | $ - 0 | ||
| 1104 | RBC Antibody Identification | 30 | EA | $ - 0 | ||
| 1105 | Rare Unit | 5 | EA | $ - 0 | ||
| 1106 | Antigen Typing ‐ Single | 230 | EA | $ - 0 | ||
| 1107 | RBC Selected Cell Panel | 1 | EA | $ - 0 | ||
| 1108 | RBC Cell Separation | 1 | EA | $ - 0 | ||
| 1109 | IgG Dissociation | 1 | EA | $ - 0 | ||
| 1110 | Dithiotreitol Treatment | 1 | EA | $ - 0 | ||
| 1111 | Neutralization P1 or Lewis | 1 | EA | $ - 0 | ||
| 1112 | Chloroquine treatment | 1 | EA | $ - 0 | ||
| 1113 | Acid Elution / Cell Elution | 30 | EA | $ - 0 | ||
| 1114 | Donath‐Landsteiner Test | 1 | EA | $ - 0 | ||
| 1115 | Irradiation ‐ Per Random Platelet | 1 | EA | $ - 0 | ||
| 1116 | Rare Donor Search thru American Rare Donor Program (ARDP) | 1 | EA | $ - 0 | ||
| 1117 | Splitting Service | 1 | EA | $ - 0 | ||
| 1118 | Type and Screen | 30 | EA | $ - 0 | ||
| 1119 | ABO Group & Rh Type | 75 | EA | $ - 0 | ||
| 1120 | Antibody Screen (Indirect Coombs) | 15 | EA | $ - 0 | ||
| 1121 | RBC Antibody Titer | 1 | EA | $ - 0 | ||
| 1122 | Direct Antiglobulin IgG (Direct Coombs) | 63 | EA | $ - 0 | ||
| 1123 | Direct Antiglobulin DAT C3 | 1 | EA | $ - 0 | ||
| 1124 | Fetal Screen | 1 | EA | $ - 0 | ||
| 1125 | Kleihauer ‐ Betke | 1 | EA | $ - 0 | ||
| 1126 | CMV Test | 1 | EA | $ - 0 | ||
| 1127 | Sickle Cell Screen | 6 | EA | $ - 0 | ||
| 1128 | LUI Elution | 1 | EA | $ - 0 | ||
| 1129 | RBC Antibody Panel | 158 | EA | $ - 0 | ||
| 1130 | Transfusion Reaction Work Up | 5 | EA | $ - 0 | ||
| 1131 | RBC Antigen Typing | 32 | EA | $ - 0 | ||
| 1132 | Adsorption | 32 | EA | $ - 0 | ||
| 1133 | Cold Agglutinin Titer | 1 | EA | $ - 0 | ||
| 1134 | ABO RH Cord | 1 | EA | $ - 0 | ||
| 1135 | Sterile Doc Quad Pack | 1 | EA | $ - 0 | ||
| 1136 | Enzyme Treatment | 2 | EA | $ - 0 | ||
| 1137 | Lookback | 1 | EA | $ - 0 | ||
| 1138 | Crossmatch ‐ Electronic | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| OTHER TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1139 | NAT (HIV ‐ I, HBV and HCV RNA) | |||||
| DONOR ONLY | 1 | EA | $ - 0 | |||
| 1140 | Non‐Donor Infectious Disease Markers 3327 | 1 | EA | $ - 0 | ||
| 1141 | Non‐Donor Infectious Disease Markers 3486, no ABO/Rh | 1 | EA | $ - 0 | ||
| 1142 | White Blood Cell Counts by Flow Cytometry | 1 | EA | $ - 0 | ||
| 1143 | Cryoprecipitate QC | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 |
TOTAL $ - 0
| OPTION YEAR TWO (October 1, 2020 – September 30, 2021) | |||||||
| BLOOD COMPONENTS | |||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | ||
| 2001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | |||
| 2002 | Whole Blood Leukoreduced Low | ||||||
| Volume | 1 | EA | $ - 0 | ||||
| 2003 | Whole Blood Leukoreduced Low | ||||||
| Volume Irradiated | 1 | EA | $ - 0 | ||||
| 2004 | Whole Blood Autologous | ||||||
| Leukoreduced | 1 | EA | $ - 0 | ||||
| 2005 | Red Blood Cells Leukoreduced | 2348 | EA | $ - 0 | |||
| 2006 | Red Blood Cells Leukoreduced | ||||||
| Deglycerolized | 1 | EA | $ - 0 | ||||
| 2007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | |||
| 2008 | Red Blood Cells Leukoreduced | ||||||
| Irradiated | 1 | EA | $ - 0 | ||||
| 2009 | Red Blood Cells Leukoreduced Low | ||||||
| Volume | 1 | EA | $ - 0 | ||||
| 2010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | |||
| 2011 | Red Blood Cells Leukoreduced | ||||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | ||||
| 2012 | Red Blood Cells Leukoreduced | ||||||
| Irradiated Washed | 1 | EA | $ - 0 | ||||
| 2013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | ||||||
| Neg.,) | 1 | EA | $ - 0 | ||||
| 2014 | Red Blood Cells Autologous | ||||||
| Leukoreduced | 1 | EA | $ - 0 | ||||
| 2015 | Red Blood Cells Autologous | ||||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | ||||
| 2016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | |||
| 2017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | |||
| 2018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | |||
| 2019 | Cryoprecipitate | 1 | EA | $ - 0 | |||
| 2020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | |||
| 2021 | Pooled Cryoprecipitate (10) | 15 | EA | $ - 0 | |||
| 2022 | Fresh Frozen Plasma | 423 | EA | $ - 0 | |||
| 2023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | |||
| 2024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | |||
| 2025 | Fresh Frozen Plasma ‐ Infant Dose | ||||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | ||||
| 2026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | |||
| 2027 | Plasma (Liquid) | 1 | EA | $ - 0 | |||
| 2028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | |||
| 2029 | Source Leukocyte | 1 | EA | $ - 0 | |||
| 2030 | Apheresis Platelets (SDP) | ||||||
| Leukoreduced | 343 | EA | $ - 0 | ||||
| 2031 | Apheresis Platelets (SDP) | ||||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | ||||
| 2032 | Apheresis Platelets (SDP) | ||||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | ||||
| 2033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | |||
| 2034 | Apheresis Platelets (SDP) | ||||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | ||||
| 2035 | Apheresis Platelets (SDP) Autologous | ||||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | ||||
| 2036 | Apheresis Granulocytes | 1 | EA | $ - 0 | |||
| 2037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | |||
| 2038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | |||
| 2039 | Pooled Platelets Leukoreduced | ||||||
| Irradiated | 1 | EA | $ - 0 | ||||
| SUBTOTAL | $ - 0 | ||||||
| CELLULAR LAB | |||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | ||
| 2040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | |||
| 2041 | SC Plasma Depletion | 1 | EA | $ - 0 | |||
| 2042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | |||
| 2043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | |||
| 2044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | |||
| 2045 | SC Cord Wash Process | 1 | EA | $ - 0 | |||
| 2046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | |||
| 2047 | Stem Cell Freight | 1 | EA | $ - 0 | |||
| 2048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | |||
| 2049 | SC CBC with automated differential | 1 | EA | $ - 0 | |||
| 2050 | SC CBC with manual differential | 1 | EA | $ - 0 | |||
| 2051 | CD34 Test | 1 | EA | $ - 0 | |||
| 2052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | |||
| 2053 | SC Trypan Blue viability | 1 | EA | $ - 0 | |||
| 2054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | |||
| 2055 | SC Sterility Check | 1 | EA | $ - 0 | |||
| 2056 | SC CD3 | 1 | EA | $ - 0 | |||
| 2057 | SC CD4 | 1 | EA | $ - 0 | |||
| 2058 | SC CD8 | 1 | EA | $ - 0 | |||
| 2059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | ||||||
| HLA AND SPECIAL HEMATOLOGY TESTING | |||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | ||
| 2060 | Platelet Crossmatch | 1 | EA | $ - 0 | |||
| 2061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | |||
| 2062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 | |||
| 2063 | Neonate Allo Thrombocytopenia Assessment | 1 | EA | $ - 0 | |||
| 2064 | Platelet Genotyping | 1 | EA | $ - 0 | |||
| 2065 | Platelet Auto Antibodies | 1 | EA | $ - 0 | |||
| 2066 | HLA ABC Typing (Class I) | 1 | EA | $ - 0 | |||
| 2067 | HLA DR/DQ Typing (Class II) | 1 | EA | $ - 0 | |||
| 2068 | HLA for Platelet Pheresis | 1 | EA | $ - 0 | |||
| 2069 | HLA‐Antibody Intermediate Resolution, Basic | 1 | EA | $ - 0 | |||
| 2070 | RBC Genotype Bioarray (HEA) | 1 | EA | $ - 0 | |||
| 2071 | HLA ‐ ABC/DR High Resolution, DQ Low Resolution | 1 | EA | $ - 0 | |||
| 2072 | Heparin Induced Thrombocytopenia Antibody (HIT) | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | ||||||
| APHERESIS AND THERAPEUTIC SERVICES | |||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | ||
| 2073 | HPC Apheresis | 1 | EA | $ - 0 | |||
| 2074 | Photopheresis Procedure | 1 | EA | $ - 0 | |||
| 2075 | Therapeutic Cellular Depletion ‐ WBC | 1 | EA | $ - 0 | |||
| 2076 | Therapeutic Phlebotomy (In Blood | ||||||
| Center) | 1 | EA | $ - 0 | ||||
| 2077 | Therapeutic phlebotomy ‐ in hospital | 1 | EA | $ - 0 | |||
| 2078 | Therapeutic phlebotomy with | ||||||
| replacement fluid ‐ in hospital | 1 | EA | $ - 0 | ||||
| 2079 | Red Blood Cell Exchange | 1 | EA | $ - 0 | |||
| 2080 | Therapeutic Cellular Depletion ‐ RBC | 1 | EA | $ - 0 | |||
| 2081 | Therapeutic Cellular Depletion ‐ | ||||||
| Platelet | 1 | EA | $ - 0 | ||||
| 2082 | Therapeutic Plasma Exchange | 74 | EA | $ - 0 | |||
| 2083 | Red Cell Prime | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | ||||||
| REFERENCE TESTING | |||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | ||
| 2084 | Radsure Label to be Irradiated | 1 | EA | $ - 0 | |||
| 2085 | Irradiation of Unit | 38 | EA | $ - 0 | |||
| 2086 | Deglycerolization of Unit | 1 | EA | $ - 0 | |||
| 2087 | Freeze Unit | 1 | EA | $ - 0 | |||
| 2088 | Freeze & Deglycerolization Unit | 1 | EA | $ - 0 | |||
| 2089 | Pooling unit(s) | 1 | EA | $ - 0 | |||
| 2090 | Thaw Unit | 1 | EA | $ - 0 | |||
| 2091 | RBC Wash | 1 | EA | $ - 0 | |||
| 2092 | Platelet Wash | 1 | EA | $ - 0 | |||
| 2093 | RBC Crossmatch (each additional unit) | 1 | EA | $ - 0 | |||
| 2094 | Non‐crossmatch set up | 1 | EA | $ - 0 | |||
| 2095 | ABO Group | 1 | EA | $ - 0 | |||
| 2096 | RH Type | 1 | EA | $ - 0 | |||
| 2097 | Chemical Treatment | 1 | EA | $ - 0 | |||
| 2098 | Aliquot Bag | 1 | EA | $ - 0 | |||
| 2099 | Confirmatory Draw | 1 | EA | $ - 0 | |||
| 2100 | Platelet (Volume Reduction Fee) | 1 | EA | $ - 0 | |||
| 2101 | Computer Antigen Search (per Antigen) | 1 | EA | $ - 0 | |||
| 2102 | Patient Complete Phenotype, Serologic | 1 | EA | $ - 0 | |||
| 2103 | Reconstitute | 1 | EA | $ - 0 | |||
| 2104 | RBC Antibody Identification | 30 | EA | $ - 0 | |||
| 2105 | Rare Unit | 5 | EA | $ - 0 | |||
| 2106 | Antigen Typing ‐ Single | 230 | EA | $ - 0 | |||
| 2107 | RBC Selected Cell Panel | 1 | EA | $ - 0 | |||
| 2108 | RBC Cell Separation | 1 | EA | $ - 0 | |||
| 2109 | IgG Dissociation | 1 | EA | $ - 0 | |||
| 2110 | Dithiotreitol Treatment | 1 | EA | $ - 0 | |||
| 2111 | Neutralization P1 or Lewis | 1 | EA | $ - 0 | |||
| 2112 | Chloroquine treatment | 1 | EA | $ - 0 | |||
| 2113 | Acid Elution / Cell Elution | 30 | EA | $ - 0 | |||
| 2114 | Donath‐Landsteiner Test | 1 | EA | $ - 0 | |||
| 2115 | Irradiation ‐ Per Random Platelet | 1 | EA | $ - 0 | |||
| 2116 | Rare Donor Search thru American Rare Donor Program (ARDP) | 1 | EA | $ - 0 | |||
| 2117 | Splitting Service | 1 | EA | $ - 0 | |||
| 2118 | Type and Screen | 30 | EA | $ - 0 | |||
| 2119 | ABO Group & Rh Type | 75 | EA | $ - 0 | |||
| 2120 | Antibody Screen (Indirect Coombs) | 15 | EA | $ - 0 | |||
| 2121 | RBC Antibody Titer | 1 | EA | $ - 0 | |||
| 2122 | Direct Antiglobulin IgG (Direct Coombs) | 63 | EA | $ - 0 | |||
| 2123 | Direct Antiglobulin DAT C3 | 1 | EA | $ - 0 | |||
| 2124 | Fetal Screen | 1 | EA | $ - 0 | |||
| 2125 | Kleihauer ‐ Betke | 1 | EA | $ - 0 | |||
| 2126 | CMV Test | 1 | EA | $ - 0 | |||
| 2127 | Sickle Cell Screen | 6 | EA | $ - 0 | |||
| 2128 | LUI Elution | 1 | EA | $ - 0 | |||
| 2129 | RBC Antibody Panel | 158 | EA | $ - 0 | |||
| 2130 | Transfusion Reaction Work Up | 5 | EA | $ - 0 | |||
| 2131 | RBC Antigen Typing | 32 | EA | $ - 0 | |||
| 2132 | Adsorption | 32 | EA | $ - 0 | |||
| 2133 | Cold Agglutinin Titer | 1 | EA | $ - 0 | |||
| 2134 | ABO RH Cord | 1 | EA | $ - 0 | |||
| 2135 | Sterile Doc Quad Pack | 1 | EA | $ - 0 | |||
| 2136 | Enzyme Treatment | 2 | EA | $ - 0 | |||
| 2137 | Lookback | 1 | EA | $ - 0 | |||
| 2138 | Crossmatch ‐ Electronic | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | ||||||
| OTHER TESTING | |||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | ||
| 2139 | NAT (HIV ‐ I, HBV and HCV RNA) | ||||||
| DONOR ONLY | 1 | EA | $ - 0 | 1 | |||
| 2140 | Non‐Donor Infectious Disease Markers 3327 | 1 | EA | $ - 0 | |||
| 2141 | Non‐Donor Infectious Disease Markers 3486, no ABO/Rh | 1 | EA | $ - 0 | |||
| 2142 | White Blood Cell Counts by Flow Cytometry | 1 | EA | $ - 0 | |||
| 2143 | Cryoprecipitate QC | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 |
TOTAL $ - 0
| OPTION YEAR THREE (October 1, 2021 – September 30, 2022) | ||||||
| BLOOD COMPONENTS | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 3001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | ||
| 3002 | Whole Blood Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 3003 | Whole Blood Leukoreduced Low | |||||
| Volume Irradiated | 1 | EA | $ - 0 | |||
| 3004 | Whole Blood Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 3005 | Red Blood Cells Leukoreduced | 2348 | EA | $ - 0 | ||
| 3006 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized | 1 | EA | $ - 0 | |||
| 3007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | ||
| 3008 | Red Blood Cells Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| 3009 | Red Blood Cells Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 3010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | ||
| 3011 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | |||
| 3012 | Red Blood Cells Leukoreduced | |||||
| Irradiated Washed | 1 | EA | $ - 0 | |||
| 3013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | |||||
| Neg.,) | 1 | EA | $ - 0 | |||
| 3014 | Red Blood Cells Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 3015 | Red Blood Cells Autologous | |||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | |||
| 3016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 3017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | ||
| 3018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | ||
| 3019 | Cryoprecipitate | 1 | EA | $ - 0 | ||
| 3020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | ||
| 3021 | Pooled Cryoprecipitate (10) | 15 | EA | $ - 0 | ||
| 3022 | Fresh Frozen Plasma | 423 | EA | $ - 0 | ||
| 3023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | ||
| 3024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | ||
| 3025 | Fresh Frozen Plasma ‐ Infant Dose | |||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | |||
| 3026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | ||
| 3027 | Plasma (Liquid) | 1 | EA | $ - 0 | ||
| 3028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | ||
| 3029 | Source Leukocyte | 1 | EA | $ - 0 | ||
| 3030 | Apheresis Platelets (SDP) | |||||
| Leukoreduced | 343 | EA | $ - 0 | |||
| 3031 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 3032 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | |||
| 3033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | ||
| 3034 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | |||
| 3035 | Apheresis Platelets (SDP) Autologous | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 3036 | Apheresis Granulocytes | 1 | EA | $ - 0 | ||
| 3037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | ||
| 3038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 3039 | Pooled Platelets Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | |||||
| CELLULAR LAB | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 3040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | ||
| 3041 | SC Plasma Depletion | 1 | EA | $ - 0 | ||
| 3042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | ||
| 3043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | ||
| 3044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | ||
| 3045 | SC Cord Wash Process | 1 | EA | $ - 0 | ||
| 3046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | ||
| 3047 | Stem Cell Freight | 1 | EA | $ - 0 | ||
| 3048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | ||
| 3049 | SC CBC with automated differential | 1 | EA | $ - 0 | ||
| 3050 | SC CBC with manual differential | 1 | EA | $ - 0 | ||
| 3051 | CD34 Test | 1 | EA | $ - 0 | ||
| 3052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | ||
| 3053 | SC Trypan Blue viability | 1 | EA | $ - 0 | ||
| 3054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | ||
| 3055 | SC Sterility Check | 1 | EA | $ - 0 | ||
| 3056 | SC CD3 | 1 | EA | $ - 0 | ||
| 3057 | SC CD4 | 1 | EA | $ - 0 | ||
| 3058 | SC CD8 | 1 | EA | $ - 0 | ||
| 3059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| HLA AND SPECIAL HEMATOLOGY TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 3060 | Platelet Crossmatch | 1 | EA | $ - 0 | ||
| 3061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | ||
| 3062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 | ||
| 3063 | Neonate Allo Thrombocytopenia Assessment | 1 | EA | $ - 0 | ||
| 3064 | Platelet Genotyping | 1 | EA | $ - 0 | ||
| 3065 | Platelet Auto Antibodies | 1 | EA | $ - 0 | ||
| 3066 | HLA ABC Typing (Class I) | 1 | EA | $ - 0 | ||
| 3067 | HLA DR/DQ Typing (Class II) | 1 | EA | $ - 0 | ||
| 3068 | HLA for Platelet Pheresis | 1 | EA | $ - 0 | ||
| 3069 | HLA‐Antibody Intermediate Resolution, Basic | 1 | EA | $ - 0 | ||
| 3070 | RBC Genotype Bioarray (HEA) | 1 | EA | $ - 0 | ||
| 3071 | HLA ‐ ABC/DR High Resolution, DQ Low Resolution | 1 | EA | $ - 0 | ||
| 3072 | Heparin Induced Thrombocytopenia Antibody (HIT) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| APHERESIS AND THERAPEUTIC SERVICES | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 3073 | HPC Apheresis | 1 | EA | $ - 0 | ||
| 3074 | Photopheresis Procedure | 1 | EA | $ - 0 | ||
| 3075 | Therapeutic Cellular Depletion ‐ WBC | 1 | EA | $ - 0 | ||
| 3076 | Therapeutic Phlebotomy (In Blood | |||||
| Center) | 1 | EA | $ - 0 | |||
| 3077 | Therapeutic phlebotomy ‐ in hospital | 1 | EA | $ - 0 | ||
| 3078 | Therapeutic phlebotomy with | |||||
| replacement fluid ‐ in hospital | 1 | EA | $ - 0 | |||
| 3079 | Red Blood Cell Exchange | 1 | EA | $ - 0 | ||
| 3080 | Therapeutic Cellular Depletion ‐ RBC | 1 | EA | $ - 0 | ||
| 3081 | Therapeutic Cellular Depletion ‐ | |||||
| Platelet | 1 | EA | $ - 0 | |||
| 3082 | Therapeutic Plasma Exchange | 74 | EA | $ - 0 | ||
| 3083 | Red Cell Prime | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| REFERENCE TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 3084 | Radsure Label to be Irradiated | 1 | EA | $ - 0 | ||
| 3085 | Irradiation of Unit | 38 | EA | $ - 0 | ||
| 3086 | Deglycerolization of Unit | 1 | EA | $ - 0 | ||
| 3087 | Freeze Unit | 1 | EA | $ - 0 | ||
| 3088 | Freeze & Deglycerolization Unit | 1 | EA | $ - 0 | ||
| 3089 | Pooling unit(s) | 1 | EA | $ - 0 | ||
| 3090 | Thaw Unit | 1 | EA | $ - 0 | ||
| 3091 | RBC Wash | 1 | EA | $ - 0 | ||
| 3092 | Platelet Wash | 1 | EA | $ - 0 | ||
| 3093 | RBC Crossmatch (each additional unit) | 1 | EA | $ - 0 | ||
| 3094 | Non‐crossmatch set up | 1 | EA | $ - 0 | ||
| 3095 | ABO Group | 1 | EA | $ - 0 | ||
| 3096 | RH Type | 1 | EA | $ - 0 | ||
| 3097 | Chemical Treatment | 1 | EA | $ - 0 | ||
| 3098 | Aliquot Bag | 1 | EA | $ - 0 | ||
| 3099 | Confirmatory Draw | 1 | EA | $ - 0 | ||
| 3100 | Platelet (Volume Reduction Fee) | 1 | EA | $ - 0 | ||
| 3101 | Computer Antigen Search (per Antigen) | 1 | EA | $ - 0 | ||
| 3102 | Patient Complete Phenotype, Serologic | 1 | EA | $ - 0 | ||
| 3103 | Reconstitute | 1 | EA | $ - 0 | ||
| 3104 | RBC Antibody Identification | 30 | EA | $ - 0 | ||
| 3105 | Rare Unit | 5 | EA | $ - 0 | ||
| 3106 | Antigen Typing ‐ Single | 230 | EA | $ - 0 | ||
| 3107 | RBC Selected Cell Panel | 1 | EA | $ - 0 | ||
| 3108 | RBC Cell Separation | 1 | EA | $ - 0 | ||
| 3109 | IgG Dissociation | 1 | EA | $ - 0 | ||
| 3110 | Dithiotreitol Treatment | 1 | EA | $ - 0 | ||
| 3111 | Neutralization P1 or Lewis | 1 | EA | $ - 0 | ||
| 3112 | Chloroquine treatment | 1 | EA | $ - 0 | ||
| 3113 | Acid Elution / Cell Elution | 30 | EA | $ - 0 | ||
| 3114 | Donath‐Landsteiner Test | 1 | EA | $ - 0 | ||
| 3115 | Irradiation ‐ Per Random Platelet | 1 | EA | $ - 0 | ||
| 3116 | Rare Donor Search thru American Rare Donor Program (ARDP) | 1 | EA | $ - 0 | ||
| 3117 | Splitting Service | 1 | EA | $ - 0 | ||
| 3118 | Type and Screen | 30 | EA | $ - 0 | ||
| 3119 | ABO Group & Rh Type | 75 | EA | $ - 0 | ||
| 3120 | Antibody Screen (Indirect Coombs) | 15 | EA | $ - 0 | ||
| 3121 | RBC Antibody Titer | 1 | EA | $ - 0 | ||
| 3122 | Direct Antiglobulin IgG (Direct Coombs) | 63 | EA | $ - 0 | ||
| 3123 | Direct Antiglobulin DAT C3 | 1 | EA | $ - 0 | ||
| 3124 | Fetal Screen | 1 | EA | $ - 0 | ||
| 3125 | Kleihauer ‐ Betke | 1 | EA | $ - 0 | ||
| 3126 | CMV Test | 1 | EA | $ - 0 | ||
| 3127 | Sickle Cell Screen | 6 | EA | $ - 0 | ||
| 3128 | LUI Elution | 1 | EA | $ - 0 | ||
| 3129 | RBC Antibody Panel | 158 | EA | $ - 0 | ||
| 3130 | Transfusion Reaction Work Up | 5 | EA | $ - 0 | ||
| 3131 | RBC Antigen Typing | 32 | EA | $ - 0 | ||
| 3132 | Adsorption | 32 | EA | $ - 0 | ||
| 3133 | Cold Agglutinin Titer | 1 | EA | $ - 0 | ||
| 3134 | ABO RH Cord | 1 | EA | $ - 0 | ||
| 3135 | Sterile Doc Quad Pack | 1 | EA | $ - 0 | ||
| 3136 | Enzyme Treatment | 2 | EA | $ - 0 | ||
| 3137 | Lookback | 1 | EA | $ - 0 | ||
| 3138 | Crossmatch ‐ Electronic | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| OTHER TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 3139 | NAT (HIV ‐ I, HBV and HCV RNA) | |||||
| DONOR ONLY | 1 | EA | $ - 0 | |||
| 3140 | Non‐Donor Infectious Disease Markers 3327 | 1 | EA | $ - 0 | ||
| 3141 | Non‐Donor Infectious Disease Markers 3486, no ABO/Rh | 1 | EA | $ - 0 | ||
| 3142 | White Blood Cell Counts by Flow Cytometry | 1 | EA | $ - 0 | ||
| 3143 | Cryoprecipitate QC | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 |
TOTAL $ - 0
| OPTION YEAR FOUR ( October 1, 2022 – September 30, 2023) | ||||||
| BLOOD COMPONENTS | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 4001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | ||
| 4002 | Whole Blood Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 4003 | Whole Blood Leukoreduced Low | |||||
| Volume Irradiated | 1 | EA | $ - 0 | |||
| 4004 | Whole Blood Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 4005 | Red Blood Cells Leukoreduced | 2348 | EA | $ - 0 | ||
| 4006 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized | 1 | EA | $ - 0 | |||
| 4007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | ||
| 4008 | Red Blood Cells Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| 4009 | Red Blood Cells Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 4010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | ||
| 4011 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | |||
| 4012 | Red Blood Cells Leukoreduced | |||||
| Irradiated Washed | 1 | EA | $ - 0 | |||
| 4013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | |||||
| Neg.,) | 1 | EA | $ - 0 | |||
| 4014 | Red Blood Cells Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 4015 | Red Blood Cells Autologous | |||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | |||
| 4016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 4017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | ||
| 4018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | ||
| 4019 | Cryoprecipitate | 1 | EA | $ - 0 | ||
| 4020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | ||
| 4021 | Pooled Cryoprecipitate (10) | 15 | EA | $ - 0 | ||
| 4022 | Fresh Frozen Plasma | 423 | EA | $ - 0 | ||
| 4023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | ||
| 4024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | ||
| 4025 | Fresh Frozen Plasma ‐ Infant Dose | |||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | |||
| 4026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | ||
| 4027 | Plasma (Liquid) | 1 | EA | $ - 0 | ||
| 4028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | ||
| 4029 | Source Leukocyte | 1 | EA | $ - 0 | ||
| 4030 | Apheresis Platelets (SDP) | |||||
| Leukoreduced | 343 | EA | $ - 0 | |||
| 4031 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 4032 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | |||
| 4033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | ||
| 4034 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | |||
| 4035 | Apheresis Platelets (SDP) Autologous | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 4036 | Apheresis Granulocytes | 1 | EA | $ - 0 | ||
| 4037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | ||
| 4038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 4039 | Pooled Platelets Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | |||||
| CELLULAR LAB | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 4040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | ||
| 4041 | SC Plasma Depletion | 1 | EA | $ - 0 | ||
| 4042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | ||
| 4043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | ||
| 4044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | ||
| 4045 | SC Cord Wash Process | 1 | EA | $ - 0 | ||
| 4046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | ||
| 4047 | Stem Cell Freight | 1 | EA | $ - 0 | ||
| 4048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | ||
| 4049 | SC CBC with automated differential | 1 | EA | $ - 0 | ||
| 4050 | SC CBC with manual differential | 1 | EA | $ - 0 | ||
| 4051 | CD34 Test | 1 | EA | $ - 0 | ||
| 4052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | ||
| 4053 | SC Trypan Blue viability | 1 | EA | $ - 0 | ||
| 4054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | ||
| 4055 | SC Sterility Check | 1 | EA | $ - 0 | ||
| 4056 | SC CD3 | 1 | EA | $ - 0 | ||
| 4057 | SC CD4 | 1 | EA | $ - 0 | ||
| 4058 | SC CD8 | 1 | EA | $ - 0 | ||
| 4059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| HLA AND SPECIAL HEMATOLOGY TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 4060 | Platelet Crossmatch | 1 | EA | $ - 0 | ||
| 4061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | ||
| 4062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 | ||
| 4063 | Neonate Allo Thrombocytopenia Assessment | 1 | EA | $ - 0 | ||
| 4064 | Platelet Genotyping | 1 | EA | $ - 0 | ||
| 4065 | Platelet Auto Antibodies | 1 | EA | $ - 0 | ||
| 4066 | HLA ABC Typing (Class I) | 1 | EA | $ - 0 | ||
| 4067 | HLA DR/DQ Typing (Class II) | 1 | EA | $ - 0 | ||
| 4068 | HLA for Platelet Pheresis | 1 | EA | $ - 0 | ||
| 4069 | HLA‐Antibody Intermediate Resolution, Basic | 1 | EA | $ - 0 | ||
| 4070 | RBC Genotype Bioarray (HEA) | 1 | EA | $ - 0 | ||
| 4071 | HLA ‐ ABC/DR High Resolution, DQ Low Resolution | 1 | EA | $ - 0 | ||
| 4072 | Heparin Induced Thrombocytopenia Antibody (HIT) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| APHERESIS AND THERAPEUTIC SERVICES | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 4073 | HPC Apheresis | 1 | EA | $ - 0 | ||
| 4074 | Photopheresis Procedure | 1 | EA | $ - 0 | ||
| 4075 | Therapeutic Cellular Depletion ‐ WBC | 1 | EA | $ - 0 | ||
| 4076 | Therapeutic Phlebotomy (In Blood | |||||
| Center) | 1 | EA | $ - 0 | |||
| 4077 | Therapeutic phlebotomy ‐ in hospital | 1 | EA | $ - 0 | ||
| 4078 | Therapeutic phlebotomy with | |||||
| replacement fluid ‐ in hospital | 1 | EA | $ - 0 | |||
| 4079 | Red Blood Cell Exchange | 1 | EA | $ - 0 | ||
| 4080 | Therapeutic Cellular Depletion ‐ RBC | 1 | EA | $ - 0 | ||
| 4081 | Therapeutic Cellular Depletion ‐ | |||||
| Platelet | 1 | EA | $ - 0 | |||
| 4082 | Therapeutic Plasma Exchange | 74 | EA | $ - 0 | ||
| 4083 | Red Cell Prime | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| REFERENCE TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 4084 | Radsure Label to be Irradiated | 1 | EA | $ - 0 | ||
| 4085 | Irradiation of Unit | 38 | EA | $ - 0 | ||
| 4086 | Deglycerolization of Unit | 1 | EA | $ - 0 | ||
| 4087 | Freeze Unit | 1 | EA | $ - 0 | ||
| 4088 | Freeze & Deglycerolization Unit | 1 | EA | $ - 0 | ||
| 4089 | Pooling unit(s) | 1 | EA | $ - 0 | ||
| 4090 | Thaw Unit | 1 | EA | $ - 0 | ||
| 4091 | RBC Wash | 1 | EA | $ - 0 | ||
| 4092 | Platelet Wash | 1 | EA | $ - 0 | ||
| 4093 | RBC Crossmatch (each additional unit) | 1 | EA | $ - 0 | ||
| 4094 | Non‐crossmatch set up | 1 | EA | $ - 0 | ||
| 4095 | ABO Group | 1 | EA | $ - 0 | ||
| 4096 | RH Type | 1 | EA | $ - 0 | ||
| 4097 | Chemical Treatment | 1 | EA | $ - 0 | ||
| 4098 | Aliquot Bag | 1 | EA | $ - 0 | ||
| 4099 | Confirmatory Draw | 1 | EA | $ - 0 | ||
| 4100 | Platelet (Volume Reduction Fee) | 1 | EA | $ - 0 | ||
| 4101 | Computer Antigen Search (per Antigen) | 1 | EA | $ - 0 | ||
| 4102 | Patient Complete Phenotype, Serologic | 1 | EA | $ - 0 | ||
| 4103 | Reconstitute | 1 | EA | $ - 0 | ||
| 4104 | RBC Antibody Identification | 30 | EA | $ - 0 | ||
| 4105 | Rare Unit | 5 | EA | $ - 0 | ||
| 4106 | Antigen Typing ‐ Single | 230 | EA | $ - 0 | ||
| 4107 | RBC Selected Cell Panel | 1 | EA | $ - 0 | ||
| 4108 | RBC Cell Separation | 1 | EA | $ - 0 | ||
| 4109 | IgG Dissociation | 1 | EA | $ - 0 | ||
| 4110 | Dithiotreitol Treatment | 1 | EA | $ - 0 | ||
| 4111 | Neutralization P1 or Lewis | 1 | EA | $ - 0 | ||
| 4112 | Chloroquine treatment | 1 | EA | $ - 0 | ||
| 4113 | Acid Elution / Cell Elution | 30 | EA | $ - 0 | ||
| 4114 | Donath‐Landsteiner Test | 1 | EA | $ - 0 | ||
| 4115 | Irradiation ‐ Per Random Platelet | 1 | EA | $ - 0 | ||
| 4116 | Rare Donor Search thru American Rare Donor Program (ARDP) | 1 | EA | $ - 0 | ||
| 4117 | Splitting Service | 1 | EA | $ - 0 | ||
| 4118 | Type and Screen | 30 | EA | $ - 0 | ||
| 4119 | ABO Group & Rh Type | 75 | EA | $ - 0 | ||
| 4120 | Antibody Screen (Indirect Coombs) | 15 | EA | $ - 0 | ||
| 4121 | RBC Antibody Titer | 1 | EA | $ - 0 | ||
| 4122 | Direct Antiglobulin IgG (Direct Coombs) | 63 | EA | $ - 0 | ||
| 4123 | Direct Antiglobulin DAT C3 | 1 | EA | $ - 0 | ||
| 4124 | Fetal Screen | 1 | EA | $ - 0 | ||
| 4125 | Kleihauer ‐ Betke | 1 | EA | $ - 0 | ||
| 4126 | CMV Test | 1 | EA | $ - 0 | ||
| 4127 | Sickle Cell Screen | 6 | EA | $ - 0 | ||
| 4128 | LUI Elution | 1 | EA | $ - 0 | ||
| 4129 | RBC Antibody Panel | 158 | EA | $ - 0 | ||
| 4130 | Transfusion Reaction Work Up | 5 | EA | $ - 0 | ||
| 4131 | RBC Antigen Typing | 32 | EA | $ - 0 | ||
| 4132 | Adsorption | 32 | EA | $ - 0 | ||
| 4133 | Cold Agglutinin Titer | 1 | EA | $ - 0 | ||
| 4134 | ABO RH Cord | 1 | EA | $ - 0 | ||
| 4135 | Sterile Doc Quad Pack | 1 | EA | $ - 0 | ||
| 4136 | Enzyme Treatment | 2 | EA | $ - 0 | ||
| 4137 | Lookback | 1 | EA | $ - 0 | ||
| 4138 | Crossmatch ‐ Electronic | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| OTHER TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 4139 | NAT (HIV ‐ I, HBV and HCV RNA) | |||||
| DONOR ONLY | 1 | EA | $ - 0 | |||
| 4140 | Non‐Donor Infectious Disease Markers 3327 | 1 | EA | $ - 0 | ||
| 4141 | Non‐Donor Infectious Disease Markers 3486, no ABO/Rh | 1 | EA | $ - 0 | ||
| 4142 | White Blood Cell Counts by Flow Cytometry | 1 | EA | $ - 0 | ||
| 4143 | Cryoprecipitate QC | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 |
| TOTAL | $ - 0 | |
| Total contract value including option years | $ - 0 |
Gainesville
| ATTACHMENT A: PRICE/COST SCHEDULE - GAINESVILLE | ||||||
| North Florida/South Gerogia VA Health System, 1601 S.W. Archer Road, Gainsville, FL 32608 | ||||||
| BASE YEAR Estimated Delivery date January 1, 2019 - September 30, 2019 | ||||||
| BLOOD COMPONENTS | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Est Unit Price | Estimated Total Price | |
| 0001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | ||
| 0002 | Whole Blood Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 0003 | Whole Blood Leukoreduced Low | |||||
| Volume Irradiated | 1 | EA | $ - 0 | |||
| 0004 | Whole Blood Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 0005 | Red Blood Cells Leukoreduced | 3338 | EA | $ - 0 | ||
| 0006 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized | 1 | EA | $ - 0 | |||
| 0007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | ||
| 0008 | Red Blood Cells Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| 0009 | Red Blood Cells Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 0010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | ||
| 0011 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | |||
| 0012 | Red Blood Cells Leukoreduced | |||||
| Irradiated Washed | 1 | EA | $ - 0 | |||
| 0013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | |||||
| Neg.,) | 1 | EA | $ - 0 | |||
| 0014 | Red Blood Cells Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 0015 | Red Blood Cells Autologous | |||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | |||
| 0016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 0017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | ||
| 0018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | ||
| 0019 | Cryoprecipitate | 1 | EA | $ - 0 | ||
| 0020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | ||
| 0021 | Pooled Cryoprecipitate (10) | 50 | EA | $ - 0 | ||
| 0022 | Fresh Frozen Plasma | 306 | EA | $ - 0 | ||
| 0023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | ||
| 0024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | ||
| 0025 | Fresh Frozen Plasma ‐ Infant Dose | |||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | |||
| 0026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | ||
| 0027 | Plasma (Liquid) | 1 | EA | $ - 0 | ||
| 0028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | ||
| 0029 | Source Leukocyte | 1 | EA | $ - 0 | ||
| 0030 | Apheresis Platelets (SDP) | |||||
| Leukoreduced | 652 | EA | $ - 0 | |||
| 0031 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 0032 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | |||
| 0033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | ||
| 0034 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | |||
| 0035 | Apheresis Platelets (SDP) Autologous | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 0036 | Apheresis Granulocytes | 1 | EA | $ - 0 | ||
| 0037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | ||
| 0038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 0039 | Pooled Platelets Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | |||||
| CELLULAR LAB | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | ||
| 0041 | SC Plasma Depletion | 1 | EA | $ - 0 | ||
| 0042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | ||
| 0043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | ||
| 0044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | ||
| 0045 | SC Cord Wash Process | 1 | EA | $ - 0 | ||
| 0046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | ||
| 0047 | Stem Cell Freight | 1 | EA | $ - 0 | ||
| 0048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | ||
| 0049 | SC CBC with automated differential | 1 | EA | $ - 0 | ||
| 0050 | SC CBC with manual differential | 1 | EA | $ - 0 | ||
| 0051 | CD34 Test | 1 | EA | $ - 0 | ||
| 0052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | ||
| 0053 | SC Trypan Blue viability | 1 | EA | $ - 0 | ||
| 0054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | ||
| 0055 | SC Sterility Check | 1 | EA | $ - 0 | ||
| 0056 | SC CD3 | 1 | EA | $ - 0 | ||
| 0057 | SC CD4 | 1 | EA | $ - 0 | ||
| 0058 | SC CD8 | 1 | EA | $ - 0 | ||
| 0059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| HLA AND SPECIAL HEMATOLOGY TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0060 | Platelet Crossmatch | 1 | EA | $ - 0 | ||
| 0061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | ||
| 0062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 | ||
| 0063 | Neonate Allo Thrombocytopenia Assessment | 1 | EA | $ - 0 | ||
| 0064 | Platelet Genotyping | 1 | EA | $ - 0 | ||
| 0065 | Platelet Auto Antibodies | 1 | EA | $ - 0 | ||
| 0066 | HLA ABC Typing (Class I) | 1 | EA | $ - 0 | ||
| 0067 | HLA DR/DQ Typing (Class II) | 1 | EA | $ - 0 | ||
| 0068 | HLA for Platelet Pheresis | 1 | EA | $ - 0 | ||
| 0069 | HLA‐Antibody Intermediate Resolution, Basic | 1 | EA | $ - 0 | ||
| 0070 | RBC Genotype Bioarray (HEA) | 1 | EA | $ - 0 | ||
| 0071 | HLA ‐ ABC/DR High Resolution, DQ Low Resolution | 1 | EA | $ - 0 | ||
| 0072 | Heparin Induced Thrombocytopenia Antibody (HIT) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| APHERESIS AND THERAPEUTIC SERVICES | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0073 | HPC Apheresis | 1 | EA | $ - 0 | ||
| 0074 | Photopheresis Procedure | 1 | EA | $ - 0 | ||
| 0075 | Therapeutic Cellular Depletion ‐ WBC | 1 | EA | $ - 0 | ||
| 0076 | Therapeutic Phlebotomy (In Blood | |||||
| Center) | 1 | EA | $ - 0 | |||
| 0077 | Therapeutic phlebotomy ‐ in hospital | 15 | EA | $ - 0 | ||
| 0078 | Therapeutic phlebotomy with | |||||
| replacement fluid ‐ in hospital | 1 | EA | $ - 0 | |||
| 0079 | Red Blood Cell Exchange | 1 | EA | $ - 0 | ||
| 0080 | Therapeutic Cellular Depletion ‐ RBC | 1 | EA | $ - 0 | ||
| 0081 | Therapeutic Cellular Depletion ‐ | |||||
| Platelet | 1 | EA | $ - 0 | |||
| 0082 | Therapeutic Plasma Exchange | 15 | EA | $ - 0 | ||
| 0083 | Red Cell Prime | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| REFERENCE TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0084 | Radsure Label to be Irradiated | 1 | EA | $ - 0 | ||
| 0085 | Irradiation of Unit | 1000 | EA | $ - 0 | ||
| 0086 | Deglycerolization of Unit | 1 | EA | $ - 0 | ||
| 0087 | Freeze Unit | 1 | EA | $ - 0 | ||
| 0088 | Freeze & Deglycerolization Unit | 1 | EA | $ - 0 | ||
| 0089 | Pooling unit(s) | 1 | EA | $ - 0 | ||
| 0090 | Thaw Unit | 1 | EA | $ - 0 | ||
| 0091 | RBC Wash | 1 | EA | $ - 0 | ||
| 0092 | Platelet Wash | 1 | EA | $ - 0 | ||
| 0093 | RBC Crossmatch (each additional unit) | 1 | EA | $ - 0 | ||
| 0094 | Non‐crossmatch set up | 1 | EA | $ - 0 | ||
| 0095 | ABO Group | 1 | EA | $ - 0 | ||
| 0096 | RH Type | 1 | EA | $ - 0 | ||
| 0097 | Chemical Treatment | 1 | EA | $ - 0 | ||
| 0098 | Aliquot Bag | 1 | EA | $ - 0 | ||
| 0099 | Confirmatory Draw | 1 | EA | $ - 0 | ||
| 0100 | Platelet (Volume Reduction Fee) | 1 | EA | $ - 0 | ||
| 0101 | Computer Antigen Search (per Antigen) | 1 | EA | $ - 0 | ||
| 0102 | Patient Complete Phenotype, Serologic | 1 | EA | $ - 0 | ||
| 0103 | Reconstitute | 1 | EA | $ - 0 | ||
| 0104 | RBC Antibody Identification | 30 | EA | $ - 0 | ||
| 0105 | Rare Unit | 5 | EA | $ - 0 | ||
| 0106 | Antigen Typing ‐ Single | 90 | EA | $ - 0 | ||
| 0107 | RBC Selected Cell Panel | 1 | EA | $ - 0 | ||
| 0108 | RBC Cell Separation | 1 | EA | $ - 0 | ||
| 0109 | IgG Dissociation | 1 | EA | $ - 0 | ||
| 0110 | Dithiotreitol Treatment | 1 | EA | $ - 0 | ||
| 0111 | Neutralization P1 or Lewis | 1 | EA | $ - 0 | ||
| 0112 | Chloroquine treatment | 1 | EA | $ - 0 | ||
| 0113 | Acid Elution / Cell Elution | 30 | EA | $ - 0 | ||
| 0114 | Donath‐Landsteiner Test | 1 | EA | $ - 0 | ||
| 0115 | Irradiation ‐ Per Random Platelet | 1 | EA | $ - 0 | ||
| 0116 | Rare Donor Search thru American Rare Donor Program (ARDP) | 1 | EA | $ - 0 | ||
| 0117 | Splitting Service | 1 | EA | $ - 0 | ||
| 0118 | Type and Screen | 30 | EA | $ - 0 | ||
| 0119 | ABO Group & Rh Type | 75 | EA | $ - 0 | ||
| 0120 | Antibody Screen (Indirect Coombs) | 15 | EA | $ - 0 | ||
| 0121 | RBC Antibody Titer | 1 | EA | $ - 0 | ||
| 0122 | Direct Antiglobulin IgG (Direct Coombs) | 63 | EA | $ - 0 | ||
| 0123 | Direct Antiglobulin DAT C3 | 1 | EA | $ - 0 | ||
| 0124 | Fetal Screen | 1 | EA | $ - 0 | ||
| 0125 | Kleihauer ‐ Betke | 1 | EA | $ - 0 | ||
| 0126 | CMV Test | 1 | EA | $ - 0 | ||
| 0127 | Sickle Cell Screen | 6 | EA | $ - 0 | ||
| 0128 | LUI Elution | 1 | EA | $ - 0 | ||
| 0129 | RBC Antibody Panel | 158 | EA | $ - 0 | ||
| 0130 | Transfusion Reaction Work Up | 5 | EA | $ - 0 | ||
| 0131 | RBC Antigen Typing | 32 | EA | $ - 0 | ||
| 0132 | Adsorption | 32 | EA | $ - 0 | ||
| 0133 | Cold Agglutinin Titer | 1 | EA | $ - 0 | ||
| 0134 | ABO RH Cord | 1 | EA | $ - 0 | ||
| 0135 | Sterile Doc Quad Pack | 1 | EA | $ - 0 | ||
| 0136 | Enzyme Treatment | 2 | EA | $ - 0 | ||
| 0137 | Lookback | 1 | EA | $ - 0 | ||
| 0138 | Crossmatch ‐ Electronic | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| OTHER TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 0139 | NAT (HIV ‐ I, HBV and HCV RNA) | |||||
| DONOR ONLY | 1 | EA | $ - 0 | |||
| 0140 | Non‐Donor Infectious Disease Markers 3327 | 1 | EA | $ - 0 | ||
| 0141 | Non‐Donor Infectious Disease Markers 3486, no ABO/Rh | 1 | EA | $ - 0 | ||
| 0142 | White Blood Cell Counts by Flow Cytometry | 1 | EA | $ - 0 | ||
| 0143 | Cryoprecipitate QC | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 |
TOTAL $ - 0
| OPTION YEAR ONE (October 1, 2019 - September 2020) | ||||||
| BLOOD COMPONENTS | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1001 | Whole Blood Leukoreduced | 1 | EA | $ - 0 | ||
| 1002 | Whole Blood Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 1003 | Whole Blood Leukoreduced Low | |||||
| Volume Irradiated | 1 | EA | $ - 0 | |||
| 1004 | Whole Blood Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 1005 | Red Blood Cells Leukoreduced | 3338 | EA | $ - 0 | ||
| 1006 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized | 1 | EA | $ - 0 | |||
| 1007 | Red Blood Cells Leukoreduced Frozen | 1 | EA | $ - 0 | ||
| 1008 | Red Blood Cells Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| 1009 | Red Blood Cells Leukoreduced Low | |||||
| Volume | 1 | EA | $ - 0 | |||
| 1010 | Red Blood Cells Leukoreduced Washed | 1 | EA | $ - 0 | ||
| 1011 | Red Blood Cells Leukoreduced | |||||
| Deglycerolized Irradiated | 1 | EA | $ - 0 | |||
| 1012 | Red Blood Cells Leukoreduced | |||||
| Irradiated Washed | 1 | EA | $ - 0 | |||
| 1013 | Red Blood Cells Leukoreduced Processing ‐ Infant (PediCells ‐ CMV | |||||
| Neg.,) | 1 | EA | $ - 0 | |||
| 1014 | Red Blood Cells Autologous | |||||
| Leukoreduced | 1 | EA | $ - 0 | |||
| 1015 | Red Blood Cells Autologous | |||||
| Leukoreduced Deglycerolized | 1 | EA | $ - 0 | |||
| 1016 | Whole Blood Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 1017 | Platelet Pheresis Pedi‐D | 1 | EA | $ - 0 | ||
| 1018 | Platelet Pheresis Pedi‐W | 1 | EA | $ - 0 | ||
| 1019 | Cryoprecipitate | 1 | EA | $ - 0 | ||
| 1020 | Pooled Cryoprecipitate (5) | 1 | EA | $ - 0 | ||
| 1021 | Pooled Cryoprecipitate (10) | 50 | EA | $ - 0 | ||
| 1022 | Fresh Frozen Plasma | 306 | EA | $ - 0 | ||
| 1023 | Fresh Frozen Plasma Cryo‐removed | 1 | EA | $ - 0 | ||
| 1024 | Fresh Frozen Plasma 0‐24 | 1 | EA | $ - 0 | ||
| 1025 | Fresh Frozen Plasma ‐ Infant Dose | |||||
| (Pediplasma Processing) | 1 | EA | $ - 0 | |||
| 1026 | Neo‐Natal Fresh Frozen Plasma | 1 | EA | $ - 0 | ||
| 1027 | Plasma (Liquid) | 1 | EA | $ - 0 | ||
| 1028 | Plasma (Liquid) Irradiated | 1 | EA | $ - 0 | ||
| 1029 | Source Leukocyte | 1 | EA | $ - 0 | ||
| 1030 | Apheresis Platelets (SDP) | |||||
| Leukoreduced | 652 | EA | $ - 0 | |||
| 1031 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 1032 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume | 1 | EA | $ - 0 | |||
| 1033 | Apheresis Platelets (SDP)/LIW Leukoreduced Irradiated Washed | 1 | EA | $ - 0 | ||
| 1034 | Apheresis Platelets (SDP) | |||||
| Leukoreduced Low Volume Irradiated | 1 | EA | $ - 0 | |||
| 1035 | Apheresis Platelets (SDP) Autologous | |||||
| Leukoreduced Irradiated | 1 | EA | $ - 0 | |||
| 1036 | Apheresis Granulocytes | 1 | EA | $ - 0 | ||
| 1037 | Apheresis Granulocytes Irradiated | 1 | EA | $ - 0 | ||
| 1038 | Pooled Platelets Leukoreduced | 1 | EA | $ - 0 | ||
| 1039 | Pooled Platelets Leukoreduced | |||||
| Irradiated | 1 | EA | $ - 0 | |||
| SUBTOTAL | $ - 0 | |||||
| CELLULAR LAB | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1040 | SC ABO Incompatible Buffy Coat Enrichment | 1 | EA | $ - 0 | ||
| 1041 | SC Plasma Depletion | 1 | EA | $ - 0 | ||
| 1042 | SC Cryopreservation (includes 1st year storage) | 1 | EA | $ - 0 | ||
| 1043 | SC Colony Forming Unit (CFU) | 1 | EA | $ - 0 | ||
| 1044 | SC Stem Cell Quality Control | 1 | EA | $ - 0 | ||
| 1045 | SC Cord Wash Process | 1 | EA | $ - 0 | ||
| 1046 | SC Cord Blood Reconstitution | 1 | EA | $ - 0 | ||
| 1047 | Stem Cell Freight | 1 | EA | $ - 0 | ||
| 1048 | SC Thawing Frozen Cell (QC Vial ea) | 1 | EA | $ - 0 | ||
| 1049 | SC CBC with automated differential | 1 | EA | $ - 0 | ||
| 1050 | SC CBC with manual differential | 1 | EA | $ - 0 | ||
| 1051 | CD34 Test | 1 | EA | $ - 0 | ||
| 1052 | SC Cellular Night and Weekend Fee | 1 | EA | $ - 0 | ||
| 1053 | SC Trypan Blue viability | 1 | EA | $ - 0 | ||
| 1054 | SC Storage greater than 1 year (storage per year) | 1 | EA | $ - 0 | ||
| 1055 | SC Sterility Check | 1 | EA | $ - 0 | ||
| 1056 | SC CD3 | 1 | EA | $ - 0 | ||
| 1057 | SC CD4 | 1 | EA | $ - 0 | ||
| 1058 | SC CD8 | 1 | EA | $ - 0 | ||
| 1059 | SC Processing Split Exceeding 4 Bags (each) | 1 | EA | $ - 0 | ||
| SUBTOTAL | $ - 0 | |||||
| HLA AND SPECIAL HEMATOLOGY TESTING | ||||||
| Line Item | Item Description | Estimated Quantity | Unit | Unit Price | Estimated Total Price | |
| 1060 | Platelet Crossmatch | 1 | EA | $ - 0 | ||
| 1061 | HLA/Platelet Antibody Screen (Serology/ELISA) | 1 | EA | $ - 0 | ||
| 1062 | HLA‐Antibody Intermediate Resolution, Complex | 1 | EA | $ - 0 |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .